Rita E. Chen

17.4k total citations · 5 hit papers
27 papers, 2.9k citations indexed

About

Rita E. Chen is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Rita E. Chen has authored 27 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Epidemiology. Recurrent topics in Rita E. Chen's work include SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (10 papers) and Viral gastroenteritis research and epidemiology (6 papers). Rita E. Chen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (10 papers) and Viral gastroenteritis research and epidemiology (6 papers). Rita E. Chen collaborates with scholars based in United States, United Kingdom and Germany. Rita E. Chen's co-authors include Michael Diamond, James Brett Case, Emma S. Winkler, Adam L. Bailey, Sean P. J. Whelan, Daved H. Fremont, Paul W. Rothlauf, Laura A. VanBlargan, Zhuoming Liu and Haiyan Zhao and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Rita E. Chen

27 papers receiving 2.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

2020 528 citations Emma S. Winkler, Adam L. Bailey et al. Nature Immunology profile →
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

2020 451 citations Longxing Cao, Inna Goreshnik et al. Science profile →
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

2021 448 citations Zhuoming Liu, Laura A. VanBlargan et al. Cell Host & Microbe profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Swathi Shrihari et al. Cell profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita E. Chen United States	20	2.3k	802	393	317	314	27	2.9k
James Brett Case United States	23	2.2k 1.0×	736 0.9×	337 0.9×	309 1.0×	288 0.9×	35	3.0k
Lili Wu China	13	2.0k 0.9×	697 0.9×	222 0.6×	291 0.9×	324 1.0×	29	2.6k
Xianwen Zhang China	15	1.9k 0.8×	668 0.8×	403 1.0×	219 0.7×	315 1.0×	49	2.5k
Xiujuan Zhang China	20	1.4k 0.6×	567 0.7×	333 0.8×	241 0.8×	196 0.6×	38	2.1k
Hongjie Xia United States	24	2.5k 1.1×	728 0.9×	521 1.3×	310 1.0×	419 1.3×	52	3.1k
Huihui Mou United States	13	2.4k 1.1×	556 0.7×	240 0.6×	262 0.8×	709 2.3×	19	2.9k
Yongfei Cai United States	20	2.2k 1.0×	1.2k 1.5×	309 0.8×	215 0.7×	321 1.0×	30	2.9k
Paul W. Rothlauf United States	9	1.7k 0.7×	535 0.7×	206 0.5×	150 0.5×	240 0.8×	12	2.0k
Akikazu Murakami Japan	16	1.4k 0.6×	700 0.9×	661 1.7×	945 3.0×	397 1.3×	46	2.9k

Countries citing papers authored by Rita E. Chen

Since Specialization

Citations

This map shows the geographic impact of Rita E. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita E. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita E. Chen more than expected).

Fields of papers citing papers by Rita E. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita E. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita E. Chen. The network helps show where Rita E. Chen may publish in the future.

Co-authorship network of co-authors of Rita E. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Rita E. Chen. A scholar is included among the top collaborators of Rita E. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita E. Chen. Rita E. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dowd, Kimberly A., Devika Sirohi, Scott D. Speer, et al.. (2023). prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis. Proceedings of the National Academy of Sciences. 120(3). e2218899120–e2218899120. 12 indexed citations

Chen, Rita E., Christine C. Yokoyama, & Milan J. Anadkat. (2023). Pemphigoid gestationis treated with dupilumab. JAAD Case Reports. 41. 10–12. 3 indexed citations

Adams, Lucas J., Laura A. VanBlargan, Zhuoming Liu, et al.. (2023). A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection. Cell Reports Medicine. 4(12). 101305–101305. 5 indexed citations

Ying, Baoling, Bradley Whitener, Laura A. VanBlargan, et al.. (2022). Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Science Translational Medicine. 14(630). eabm3302–eabm3302. 36 indexed citations

Farnsworth, Christopher W, James Brett Case, Karl Hock, et al.. (2021). Assessment of serological assays for identifying high titer convalescent plasma. Transfusion. 61(9). 2658–2667. 10 indexed citations

Winkler, Emma S., Pavlo Gilchuk, Jinsheng Yu, et al.. (2021). Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 184(7). 1804–1820.e16. 183 indexed citations breakdown →

Case, James Brett, Rita E. Chen, Longxing Cao, et al.. (2021). Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host & Microbe. 29(7). 1151–1161.e5. 40 indexed citations

Hassan, Ahmed O., Swathi Shrihari, Matthew J. Gorman, et al.. (2021). An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Reports. 36(4). 109452–109452. 86 indexed citations

Hassan, Ahmed O., Friederike Feldmann, Haiyan Zhao, et al.. (2021). A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Reports Medicine. 2(4). 100230–100230. 81 indexed citations

10.

Liu, Zhuoming, Laura A. VanBlargan, Louis-Marie Bloyet, et al.. (2021). Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host & Microbe. 29(3). 477–488.e4. 448 indexed citations breakdown →

11.

Errico, John M., Haiyan Zhao, Rita E. Chen, et al.. (2021). Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD. Cell Reports. 37(4). 109881–109881. 17 indexed citations

12.

Chen, Rita E., Brittany Smith, John M. Errico, et al.. (2021). Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host & Microbe. 29(11). 1634–1648.e5. 8 indexed citations

13.

Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 184(9). 2316–2331.e15. 215 indexed citations breakdown →

14.

Tang, Mei San, James Brett Case, Rita E. Chen, et al.. (2020). Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays. Clinical Chemistry. 66(12). 1538–1547. 80 indexed citations

15.

Winkler, Emma S., Adam L. Bailey, Natasha M. Kafai, et al.. (2020). SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nature Immunology. 21(11). 1327–1335. 528 indexed citations breakdown →

16.

Cao, Longxing, Inna Goreshnik, Brian Coventry, et al.. (2020). De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science. 370(6515). 426–431. 451 indexed citations breakdown →

17.

Rothlauf, Paul W., Zhuoming Liu, Timothy K. Soh, et al.. (2020). Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proceedings of the National Academy of Sciences. 117(34). 20803–20813. 133 indexed citations

18.

Case, James Brett, Paul W. Rothlauf, Rita E. Chen, et al.. (2020). Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host & Microbe. 28(3). 465–474.e4. 115 indexed citations

19.

Case, James Brett, Adam L. Bailey, Arthur S. Kim, Rita E. Chen, & Michael Diamond. (2020). Growth, detection, quantification, and inactivation of SARS-CoV-2. Virology. 548. 39–48. 134 indexed citations

20.

Chen, Rita E., Anshu P. Gounder, Amelia K. Pinto, et al.. (2016). Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice. Virology. 494. 89–99. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact